Maccura Biotechnology Co., Ltd., headquartered in China, is a prominent player in the biotechnology industry, specialising in the development and manufacturing of innovative diagnostic solutions. Founded in 2000, the company has established a strong presence in major operational regions across Asia and beyond, focusing on in vitro diagnostics (IVD) and related healthcare technologies. Maccura's core products include a range of diagnostic reagents and instruments that stand out for their accuracy and reliability. The company is recognised for its commitment to quality and has achieved significant milestones, including various certifications that underscore its market position. With a reputation for excellence, Maccura Biotechnology continues to advance healthcare solutions, making a notable impact in the global diagnostics landscape.
How does Maccura Biotechnology Co.Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Maccura Biotechnology Co.Ltd's score of 22 is lower than 79% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Maccura Biotechnology Co. Ltd, headquartered in CN, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. As of now, Maccura Biotechnology Co. Ltd does not inherit emissions data from any parent or related organizations, indicating that their climate commitments and emissions management strategies are independently developed. Without specific emissions data or reduction initiatives, it is unclear how the company is addressing its carbon footprint or contributing to climate action within the biotechnology sector. In the absence of concrete data, it is essential for Maccura Biotechnology Co. Ltd to establish clear climate commitments and reduction targets to align with industry standards and contribute effectively to global climate goals.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Maccura Biotechnology Co.Ltd has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

